“If this blog helped you out, don’t keep it to yourself—share the link on your socials!” 👍 “Like what you read? Spread the love and share this blog on your social media.” 👍 “Found this useful? Hit share and let your friends know too!” 👍 “If you enjoyed this post, please share the URL with your friends online.” 👍 “Sharing is caring—drop this link on your social media if it helped you.”

Sunday, August 10, 2025

Shingles


Shingles (Herpes Zoster)

Definition
Shingles is a reactivation of the varicella-zoster virus (the same virus that causes chickenpox), leading to a painful, blistering skin rash typically confined to one side of the body along a single dermatome.


Cause

  • After chickenpox infection, varicella-zoster virus remains dormant in sensory nerve ganglia

  • Reactivates years later when immunity wanes due to age, illness, or immunosuppression


Risk Factors

  • Age >50 years

  • Immunosuppression (HIV, chemotherapy, long-term corticosteroid use)

  • Physical or emotional stress

  • Chronic diseases (e.g., diabetes)


Pathophysiology

  • Reactivation in dorsal root or cranial nerve ganglia

  • Viral replication causes inflammation of nerve and skin supplied by the affected nerve

  • Leads to neuropathic pain and vesicular rash


Clinical Features

Prodromal Phase (1–5 days before rash)

  • Localized burning, tingling, or shooting pain in one dermatome

  • Malaise, headache, mild fever

Rash Phase

  • Erythematous patches evolving into grouped vesicles

  • Unilateral, dermatomal distribution

  • Vesicles crust over in 7–10 days

  • Common sites: thoracic dermatomes, trigeminal nerve (especially ophthalmic branch)

Post-herpetic Phase

  • Pain persisting >90 days after rash healing (post-herpetic neuralgia)


Complications

  • Post-herpetic neuralgia (most common)

  • Herpes zoster ophthalmicus (can cause vision loss)

  • Bacterial superinfection of lesions

  • Neurological: meningitis, encephalitis, myelitis

  • Hearing loss or facial paralysis (Ramsay Hunt syndrome)


Diagnosis

  • Usually clinical based on unilateral, dermatomal vesicular rash

  • PCR or direct fluorescent antibody testing from vesicle fluid if uncertain


Treatment

Antiviral Therapy (start within 72 hours of rash onset for best effect)

  • Acyclovir 800 mg orally five times daily for 7 days

  • Valacyclovir 1 g orally three times daily for 7 days (preferred for easier dosing)

  • Famciclovir 500 mg orally three times daily for 7 days

Pain Management

  • Paracetamol 500–1000 mg every 4–6 hours (max 4 g/day)

  • Ibuprofen 200–400 mg every 6–8 hours as needed

  • Severe pain: codeine or tramadol short-term

  • Neuropathic pain: amitriptyline 10–25 mg at night or gabapentin 300 mg TID (titrate as tolerated)

Skin Care

  • Keep lesions clean and dry

  • Loose clothing to reduce irritation

Special Cases

  • Ophthalmic involvement → urgent ophthalmology referral

  • Immunocompromised patients → consider IV acyclovir 10 mg/kg every 8 hours for 7–10 days


Prevention

  • Zoster vaccine (Shingrix®) recommended for adults ≥50 years and high-risk individuals ≥18 years


Quick-Reference Clinical Chart — Shingles

FeatureDetails
CauseReactivation of varicella-zoster virus
Risk FactorsAge >50, immunosuppression, stress, chronic illness
SymptomsProdrome: localized pain/tingling → unilateral vesicular rash along dermatome
Common SitesThoracic dermatomes, trigeminal nerve
ComplicationsPost-herpetic neuralgia, vision loss, bacterial infection
Antiviral TreatmentAcyclovir 800 mg PO 5×/day × 7 days OR Valacyclovir 1 g PO TID × 7 days OR Famciclovir 500 mg PO TID × 7 days
Pain ControlParacetamol 500–1000 mg Q4–6h PRN, Ibuprofen 200–400 mg Q6–8h PRN, neuropathic pain meds if needed
Special ManagementOphthalmology referral if eye involvement; IV acyclovir if immunocompromised
PreventionShingrix vaccine for ≥50 years or high-risk adults



No comments:

Post a Comment